170 related articles for article (PubMed ID: 10189556)
1. Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities.
Steiner G
Diabetes Care; 1999 Apr; 22 Suppl 3():C6-9. PubMed ID: 10189556
[No Abstract] [Full Text] [Related]
2. Risk factors of macrovascular disease in diabetes mellitus.
Jarrett RJ
Horm Metab Res Suppl; 1985; 15():1-3. PubMed ID: 3865876
[No Abstract] [Full Text] [Related]
3. [Role of endothelin I and angiotensin II in type 2 diabetics with coronary disease].
Mundo-Sagardía J; Altieri P; Banch H; González R; Escobales N; Crespo M; Rodríguez-Orengo J; Cardona F; Torrado J
Bol Asoc Med P R; 2003; 95(5):45-50. PubMed ID: 15008361
[No Abstract] [Full Text] [Related]
4. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
[TBL] [Abstract][Full Text] [Related]
5. Diabetic vascular disease.
Feingold KR; Siperstein MD
Adv Intern Med; 1986; 31():309-40. PubMed ID: 3511622
[No Abstract] [Full Text] [Related]
6. Triglycerides in diabetes: time for action?
Stewart MW; Laker MF
Diabet Med; 1994 Oct; 11(8):725-7. PubMed ID: 7851064
[No Abstract] [Full Text] [Related]
7. Plasma lipid abnormalities and risk factors for coronary artery disease in Japanese subjects with diabetes mellitus and glucose intolerance.
Yamada N; Yoshinaga H; Gotoda T; Harada K; Shimada M; Ohsuga J; Akanuma Y; Murase T
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S215-20. PubMed ID: 7859608
[TBL] [Abstract][Full Text] [Related]
8. [Hemostasis and lipid metabolism in patients with non-insulin- dependent diabetes mellitus and angiopathy of the lower extremities].
Mamedgasanov RM; Semavin IE; Smirnova LM; Rudenko GR; Riazanov IuI
Klin Med (Mosk); 1989 Aug; 67(8):74-6. PubMed ID: 2811244
[TBL] [Abstract][Full Text] [Related]
9. A study of aspirin resistance in type 2 diabetes.
Singla MK; Lahiri P; Mukhopadhyay P; Pandit K; Chaudhuri U; Chowdhury S
J Indian Med Assoc; 2008 Nov; 106(11):720, 722-3, 740. PubMed ID: 19368097
[TBL] [Abstract][Full Text] [Related]
10. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.
Janka HU; Standl E
Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556
[No Abstract] [Full Text] [Related]
11. Framingham risk equations underestimate coronary heart disease risk in diabetes.
Stevens RJ; Coleman RL; Holman RR
Diabet Med; 2005 Feb; 22(2):228. PubMed ID: 15660747
[No Abstract] [Full Text] [Related]
12. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance.
Stern M
Diabetes Care; 1999 Apr; 22 Suppl 3():C2-5. PubMed ID: 10189555
[No Abstract] [Full Text] [Related]
13. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
Haffner SM
Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL).
Mazza A; Zamboni S; Rizzato E; Pessina AC; Tikhonoff V; Schiavon L; Casiglia E
Acta Diabetol; 2007 Sep; 44(3):99-105. PubMed ID: 17721747
[TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemia in noninsulin dependent diabetes mellitus.
Schonfeld G
Semin Thromb Hemost; 1988 Apr; 14(2):184-8. PubMed ID: 3061003
[No Abstract] [Full Text] [Related]
17. Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
Thomason MJ; Colhoun HM; Livingstone SJ; Mackness MI; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Fuller JH;
Diabet Med; 2004 Aug; 21(8):901-5. PubMed ID: 15270795
[TBL] [Abstract][Full Text] [Related]
18. Improving macrovascular outcomes in type 2 diabetes: Outcome studies in cardiovascular risk and metabolic control.
Schneider CA
Curr Med Res Opin; 2006; 22 Suppl 2():S15-26. PubMed ID: 16914072
[TBL] [Abstract][Full Text] [Related]
19. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
Bruckert E; Baccara-Dinet M; Eschwege E
Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
[TBL] [Abstract][Full Text] [Related]
20. Effects of glycaemic control on cardiovascular disease in diabetic American Indians: the Strong Heart Study.
Lu WQ; Resnick HE; Jablonski KA; Jain AK; Jones KL; Robbins DC; Howard BV
Diabet Med; 2004 Apr; 21(4):311-7. PubMed ID: 15049931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
